NASDAQ:NH

NantHealth - NH Stock Forecast, Price & News

$0.55

+0.02 (+3.08%)

(As of 08/18/2022 03:59 PM ET)

Add

Compare

Today's Range: $0.53
▼
$0.55
50-Day Range: $0.42
▼
$0.61
52-Week Range: $0.40
▼
$2.51

Volume: 200 shs
Average Volume: 29,755 shs
Market Capitalization: $62.99 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

NantHealth MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
1.12% of Float Sold Short
Dividend Strength: N/A
Sustainability: -0.69
Upright™ Environmental Score
News Sentiment: 0.70
Based on 4 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.37) to ($0.32) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.75 out of 5 stars

Medical Sector

957th out of 1,119 stocks

Data Processing & Preparation Industry

66th out of 76 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for NantHealth.

3.0

Short Interest

Percentage of Shares Shorted
1.12% of the float of NantHealth has been sold short.
Short Interest Ratio / Days to Cover
NantHealth has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in NantHealth has recently increased by 31.61%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
NantHealth does not currently pay a dividend.
Dividend Growth
NantHealth does not have a long track record of dividend growth.

4.3

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
NantHealth has received a 64.10% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Private health advocacy services", "Computerized clinical decision support software", and "Patient flow management systems" products. See details.
Environmental Sustainability
The Environmental Impact score for NantHealth is -0.69.

2.1

News and Social Media Coverage

News Sentiment
NantHealth has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for NantHealth this week, compared to 1 article on an average week.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, NantHealth insiders have not sold or bought any company stock.
Percentage Held by Insiders
60.80% of the stock of NantHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 5.26% of the stock of NantHealth is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for NantHealth are expected to grow in the coming year, from ($0.37) to ($0.32) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of NantHealth is -1.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of NantHealth is -1.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

About NantHealth (NASDAQ:NH) Stock

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers Quadris, a data solution that includes multi-data analysis, reporting, and professional services. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

Analyst Ratings Changes

Separately, StockNews.com began coverage on NantHealth in a report on Wednesday. They issued a "hold" rating for the company.

NantHealth Stock Down 4.6 %

NASDAQ:NH opened at $0.53 on Thursday. NantHealth has a twelve month low of $0.40 and a twelve month high of $2.51. The business has a 50-day moving average price of $0.51 and a 200-day moving average price of $0.66.

Receive NH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter.

NH Stock News Headlines

August 18, 2022 | americanbankingnews.com

NantHealth (NASDAQ:NH) Now Covered by Analysts at StockNews.com

August 12, 2022 | finance.yahoo.com

Sarah Chavarria Named President of Delta Dental of California and Affiliates - Yahoo Finance

August 5, 2022 | fool.com

NantHealth, Inc. (NH) Q2 2022 Earnings Call Transcript - The Motley Fool

August 5, 2022 | finance.yahoo.com

NantHealth, Inc. (NH) Q2 2022 Earnings Call Transcript

August 4, 2022 | businesswire.com

NantHealth Reports 2022 Second Quarter Financial Results - Business Wire

August 4, 2022 | finance.yahoo.com

NantHealth Reports 2022 Second Quarter Financial Results

August 3, 2022 | americanbankingnews.com

NantHealth (NASDAQ:NH) Coverage Initiated at StockNews.com

August 1, 2022 | finance.yahoo.com

NantHealth to Report 2022 Second-Quarter Financial Results and Host Conference Call on Thursday, August 4 - Yahoo Finance

August 1, 2022 | businesswire.com

NantHealth to Report 2022 Second-Quarter Financial Results and Host Conference Call on Thursday, August 4 - Business Wire

August 1, 2022 | finance.yahoo.com

NantHealth to Report 2022 Second-Quarter Financial Results and Host Conference Call on Thursday, August 4

July 12, 2022 | streetinsider.com

Xealth Expands Leadership Team with Appointments of Joe Sedlak, RN, and Laurance Stuntz - StreetInsider.com

July 8, 2022 | finance.yahoo.com

NantHealth (NASDAQ:NH) investors are sitting on a loss of 90% if they invested five years ago

June 8, 2022 | finance.yahoo.com

The OpenNMS Group Launches Horizon 30, the Latest Major Release of its Open Source Network Monitoring Solution, Featuring Enhanced Capabilities Designed for the Enterprise

May 17, 2022 | finance.yahoo.com

NantHealth NaviNet Open Wins "Healthcare Insurance Innovation Award" in 2022 MedTech Breakthrough Awards Program - Yahoo Finance

May 6, 2022 | finance.yahoo.com

NantHealth, Inc. (NH) Q1 2022 Earnings Call Transcript

May 5, 2022 | finance.yahoo.com

NantHealth Reports 2022 First Quarter Financial Results - Yahoo Finance

May 5, 2022 | finance.yahoo.com

NantHealth Reports 2022 First Quarter Financial Results

May 4, 2022 | benzinga.com

A Preview Of NantHealth's Earnings - Benzinga - Benzinga

May 2, 2022 | businesswire.com

NantHealth to Report 2022 First-quarter Financial Results and Host Conference Call on Thursday, May 5 - Business Wire

May 2, 2022 | finance.yahoo.com

NantHealth to Report 2022 First-quarter Financial Results and Host Conference Call on Thursday, May 5

April 14, 2022 | nasdaq.com

NantHealth, Inc. Common Stock (NH)

March 31, 2022 | businesswire.com

The OpenNMS Group Releases OpenNMS Meridian 2022 with Enhanced Network Monitoring and Security Capabilities - Business Wire

March 31, 2022 | finance.yahoo.com

The OpenNMS Group Releases OpenNMS Meridian 2022 with Enhanced Network Monitoring and Security Capabilities - Yahoo Finance

March 31, 2022 | finance.yahoo.com

The OpenNMS Group Releases OpenNMS Meridian 2022 with Enhanced Network Monitoring and Security Capabilities

March 7, 2022 | businesswire.com

NantHealth and Leading Nonprofit Multi-State Health Plan Scale Partnership to Increase Services for Members with Cancer - Business Wire

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive NH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter.

NH Company Calendar

Last Earnings: 11/04/2021
Today: 8/18/2022
Next Earnings (Estimated): 11/03/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Data processing & preparation
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:NH
Previous Symbol: NYSE:NH
CUSIP: N/A
CIK: 1566469
Web: www.nanthealth.com
Phone: (310) 883-1300
Fax: N/A
Employees: 326
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.48)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-58,260,000.00
Net Margins: -88.54%
Pretax Margin: -88.50%
Return on Equity: N/A
Return on Assets: -27.06%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.63
Quick Ratio: 0.63

Sales & Book Value

Annual Sales: $62.65 million
Price / Sales: 1.01
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($1.63) per share
Price / Book: -0.33

Miscellaneous

Outstanding Shares: 115,550,000
Free Float: 45,296,000
Market Cap: $62.99 million
Optionable: Optionable
Beta: 1.82

Key Executives

Dr. Patrick Soon-Shiong F.A.C.S. (Age 69)
FACS, FRCS (C), M.Sc., Founder, Chairman & CEO
Mr. Bob Petrou (Age 50)
Chief Financial Officer
Comp: $556.27k
Mr. Ronald Allen Louks (Age 57)
Chief Operating Officer
Comp: $837.05k
Mr. Brandon Villery
Sr. VP, Gen. Counsel & Corp. Sec.
Mr. Mark Mozley
Sr. VP of Corp. Devel.
Mr. Jerry Magin
Sr. VP of Global Sales & Marketing
Mr. Arlyn R. Small Jr.
Sr. VP of HR
Mr. Keith Krebs
Sr. VP of Client Services
Mr. Chris House
Sr. VP of Product Management & Devel.
Dr. Tiffany Avery
Chief Medical Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

NH Stock - Frequently Asked Questions

Should I buy or sell NantHealth stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NantHealth in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NH shares.
View NH analyst ratings or view top-rated stocks.
How have NH shares performed in 2022?: NantHealth's stock was trading at $1.0550 at the beginning of 2022. Since then, NH stock has decreased by 49.9% and is now trading at $0.5288.
View the best growth stocks for 2022 here.
When is NantHealth's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our NH earnings forecast.
How were NantHealth's earnings last quarter?: NantHealth, Inc. (NASDAQ:NH) released its earnings results on Thursday, November, 4th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.08) by $0.02. The company had revenue of $14.36 million for the quarter, compared to analyst estimates of $17.70 million. During the same period last year, the firm posted ($0.08) earnings per share.
What is Patrick Soon-Shiong's approval rating as NantHealth's CEO?: 82 employees have rated NantHealth Chief Executive Officer Patrick Soon-Shiong on Glassdoor.com. Patrick Soon-Shiong has an approval rating of 49% among the company's employees. This puts Patrick Soon-Shiong in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of NantHealth own?: Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Micron Technology (MU), NantKwest (NK), AbbVie (ABBV), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH) and Netflix (NFLX).

When did NantHealth IPO?: (NH) raised $91 million in an IPO on Thursday, June 2nd 2016. The company issued 6,500,000 shares at a price of $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.
What is NantHealth's stock symbol?: NantHealth trades on the NASDAQ under the ticker symbol "NH."
Who are NantHealth's major shareholders?: NantHealth's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Atria Wealth Solutions Inc. (0.43%), Millennium Management LLC (0.23%), State Street Corp (0.11%), Northern Trust Corp (0.08%), Hartline Investment Corp (0.02%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Patrick Soon-Shiong and Ronald Allen Louks.
View institutional ownership trends.
How do I buy shares of NantHealth?: Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is NantHealth's stock price today?: One share of NH stock can currently be purchased for approximately $0.53.
How much money does NantHealth make?: NantHealth (NASDAQ:NH) has a market capitalization of $61.10 million and generates $62.65 million in revenue each year. The company earns $-58,260,000.00 in net income (profit) each year or ($0.48) on an earnings per share basis.
How many employees does NantHealth have?: The company employs 326 workers across the globe.
How can I contact NantHealth?: NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The official website for the company is www.nanthealth.com. The company can be reached via phone at (310) 883-1300 or via email at ir@nanthealth.com.

This page (NASDAQ:NH) was last updated on 8/18/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

NantHealth - NH Stock Forecast, Price & News

NantHealth MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month